Delivery Order SPE2DR25D3301-SPE2DR26F21AY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.66 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of July 18, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, is executing this order as a child contract under its broader...
- The Defense Logistics Agency awarded a $1,155.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablets (21-count packages) on December 30, 2025, with completion targeted for December 31, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,783.16 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LOESTRIN 21 1-20 TABLET 21S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $1.81K to AmerisourceBergen Drug Corp for LOESTRIN 21 1-20 tablets (21-count packages) on August 5, 2025, with completion targeted for August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,400.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LOESTRIN FE 1-20 tablets (28-count packaging) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a non-set-aside, competitively awarded contract executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-count packages) valued at $8,991.35 under a firm fixed-price contract type. The award, announced on June 9, 2025, with an ultimate completion date of June 10, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, supplying this...
- The Defense Logistics Agency awarded a delivery order valued at $2,733.36 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was issued without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is structured as a child contract under AmerisourceBergen's parent company, Cencora, Inc.,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $3,422.36 contract is for the supply of 4564205610 LOESTRIN 21 1.5-30 TABLET 21S, a pharmaceutical product, with an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA,...
- The Defense Logistics Agency awarded a delivery order valued at $3,500.57 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance taking place at its corporate office...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F21AYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,523.56 to AmerisourceBergen Drug Corp for LOESTRIN 21 1.5-30 tablets (21-tablet package) on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order was awarded without a set-aside designation, indicating competitive selection. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at up to $999,999,999.00 and runs through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, and medical commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/20/26 |